JPMorgan--26th annual healthcare conference. Part 3.
Gale
Sophie
S
Thomson Scientific, 77 Hatton Garden, London, EC1N 8JS, UK. sophie.gale@thomson.com
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy; D003287:Contrast Media / Q000737:chemistry; D003695:Delivery of Health Care / Q000379:methods* / Q000639:trends; D003911:Dextrans; D004345:Drug Industry / Q000379:methods* / Q000639:trends; D052203:Ferrosoferric Oxide / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000737:chemistry; D058185:Magnetite Nanoparticles; D036103:Nanotechnology / Q000379:methods / Q000639:trends; D010087:Oxides / Q000737:chemistry
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D007501:Iron; D052203:Ferrosoferric Oxide